Skip to main content

Table 5 Statistical analysis of XMRV prevalence and RNASEL genotyping

From: No evidence of XMRV in prostate cancer cohorts in the Midwestern United States

 

XMRV+ a

XMRV-b

x 2c

RNASEL RR+RQ

6

124

0

RNASEL QQ

0

20

0.962

  1. a XMRV positive samples from real time PCR.
  2. b XMRV negative samples from real time PCR.
  3. c Statistical results from chi-square (x2) tests.
Back to article page

Retrovirology

ISSN: 1742-4690

Contact us